Active	Status	Sponsor type	Region	Phase	Filter
7 Active 0 Inactive 7 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Gutman, Jonathan A
NCT04103879 / 2022-002458-26: US Study of UM171-Expanded CB in Patients With High Risk Leukemia/Myelodysplasia	Active, not recruiting	2	30	Europe, US	ECT-001-CB (UM171-Expanded Cord Blood Transplant)	ExCellThera inc., Fred Hutchinson Cancer Center	High Risk Hematological Malignancy, Cord Blood Transplant	02/26	02/26
Allo, NCT05775718: Shingrix in Recipients of geneic Transplants	Recruiting	2	55	US	Zoster Vaccine Recombinant, Shingrix	University of Colorado, Denver, GlaxoSmithKline	Bone Marrow Transplant, Stem Cell Transplant	05/25	12/30
20-1319.cc, NCT05287568: CC-486 and Venetoclax for Acute Myeloid Leukemia	Recruiting	1	35	US	Venetoclax, ABT-199, Abbvie, CC-486	University of Colorado, Denver, Bristol-Myers Squibb	AML	03/27	03/29